FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent advisory panel of the Food and Drug Administration rejected the use of MDMA-assisted therapy for post-traumatic stress disorder on Tuesday, highlighting the unparalleled regulatory challenges of a novel therapy using an illegal drug commonly known as Ecstasy. Before the vote, members of the panel raised concerns about the designs of the two studies…